AtriCure, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
AtriCure, Inc. (ATRC) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $2.70 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-02.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-11-02
- AtriCure, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$2.60M.
- AtriCure, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$431.00K.
- AtriCure, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was $5.73M, a 18.15% decline year-over-year.
- AtriCure, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was $6.81M.
- AtriCure, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$12.08M.
- AtriCure, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$10.50M.
- AtriCure, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$30.62M.
- AtriCure, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$14.15M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-09-30 | -$2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$3.03M derived: sum of 2 quarters · filed 2017-11-02 | $2.70M 10-Q · filed 2017-11-02 | $9.51M derived: sum of 4 quarters · filed 2017-11-02 |
| 2017-06-30 | -$431.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $5.29M 10-Q · filed 2017-07-28 | $12.11M derived: sum of 3 quarters · filed 2017-07-28 | $7.09M derived: sum of 4 quarters · filed 2017-11-02 |
| 2017-03-31 | $5.73M 10-Q · filed 2017-05-05 | $12.54M derived: sum of 2 quarters · filed 2017-05-05 | $7.52M derived: sum of 3 quarters · filed 2017-11-02 | -$13.35M derived: sum of 4 quarters · filed 2017-11-02 |
| 2016-12-31 | $6.81M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $1.80M derived: sum of 2 quarters · filed 2017-11-02 | -$19.07M derived: sum of 3 quarters · filed 2017-11-02 | -$12.08M 10-K · filed 2017-03-08 |
| 2016-09-30 | -$5.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$25.89M derived: sum of 2 quarters · filed 2017-11-02 | -$18.89M 10-Q · filed 2017-11-02 | -$21.63M derived: sum of 4 quarters · filed 2017-11-02 |
| 2016-06-30 | -$20.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | -$13.88M 10-Q · filed 2017-07-28 | -$16.61M derived: sum of 3 quarters · filed 2017-07-28 | -$25.65M derived: sum of 4 quarters · filed 2017-07-28 |
| 2016-03-31 | $7.00M 10-Q · filed 2017-05-05 | $4.26M derived: sum of 2 quarters · filed 2017-05-05 | -$4.78M derived: sum of 3 quarters · filed 2017-05-05 | -$6.06M derived: sum of 4 quarters · filed 2017-05-05 |
| 2015-12-31 | -$2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | -$11.78M derived: sum of 2 quarters · filed 2017-03-08 | -$13.06M derived: sum of 3 quarters · filed 2017-03-08 | -$10.50M 10-K · filed 2017-03-08 |
| 2015-09-30 | -$9.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | -$10.32M derived: sum of 2 quarters · filed 2016-10-28 | -$7.77M 10-Q · filed 2016-10-28 | -$17.20M derived: sum of 4 quarters · filed 2017-03-08 |
| 2015-06-30 | -$1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $1.27M 10-Q · filed 2016-08-05 | -$8.16M derived: sum of 3 quarters · filed 2017-03-08 | -$13.30M derived: sum of 4 quarters · filed 2017-03-08 |
| 2015-03-31 | $2.56M 10-Q · filed 2016-04-29 | -$6.88M derived: sum of 2 quarters · filed 2017-03-08 | -$12.02M derived: sum of 3 quarters · filed 2017-03-08 | -$35.48M derived: sum of 4 quarters · filed 2017-03-08 |
| 2014-12-31 | -$9.44M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | -$14.57M derived: sum of 2 quarters · filed 2017-03-08 | -$38.04M derived: sum of 3 quarters · filed 2017-03-08 | -$30.62M 10-K · filed 2017-03-08 |
| 2014-09-30 | -$5.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | -$28.60M derived: sum of 2 quarters · filed 2015-10-30 | -$21.19M 10-Q · filed 2015-10-30 | -$29.12M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$23.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | -$16.05M 10-Q · filed 2015-07-31 | -$23.98M derived: sum of 3 quarters · filed 2016-02-29 | -$29.36M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $7.41M 10-Q · filed 2015-05-01 | -$523.00K derived: sum of 2 quarters · filed 2016-02-29 | -$5.90M derived: sum of 3 quarters · filed 2016-02-29 | -$5.29M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | -$7.94M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$13.32M derived: sum of 2 quarters · filed 2016-02-29 | -$12.70M derived: sum of 3 quarters · filed 2016-02-29 | -$14.15M 10-K · filed 2016-02-29 |
| 2013-09-30 | -$5.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | -$4.76M derived: sum of 2 quarters · filed 2014-10-31 | -$6.21M 10-Q · filed 2014-10-31 | |
| 2013-06-30 | $614.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-30 | -$835.00K 10-Q · filed 2014-07-30 | ||
| 2013-03-31 | -$1.45M 10-Q · filed 2014-04-30 | |||
| 2012-12-31 | -$2.80M 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |